1-20 of 39
Ahmed Sawas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Methods for Identification of Blood Product Transfusions in a Cohort of Myelofibrosis Patients: An Assessment of Data Capture Using Insurance Claims and Electronic Health Record Abstraction

Anthony Proli, Ahmed Sawas, Gene Ho, Jingru Wang, Christina Fullerton
Journal: Blood
Blood (2023) 142 (Supplement 1): 7292.
https://doi.org/10.1182/blood-2023-189374
Published: 2023
Journal Articles

The Effect of Preemptive Rituximab Treatment in Patients with EBV Viremia after Solid Organ Transplantation on the Development of Post-Transplant Lymphoproliferative Disorder

Evelyn H. Orlando, Patrick Gould, Brian Cuzzo, Maegan Ford, Yuxuan Chen, Alexander Sanjurjo, Benjamin May, Demetra Tsapepas, Rebecca J. Leeman-Neill, Govind Bhagat, Geoffrey Dube, Heather Morris, Selim Arcasoy, Farhana Latif, Mercedes Martinez, Marcus Pereira, Andrew H. Lipsky, Ahmed Sawas, Ran Reshef, Barbara Pro, Hua-Jay J. Cherng, Jennifer E. Amengual
Journal: Blood
Blood (2023) 142 (Supplement 1): 990.
https://doi.org/10.1182/blood-2023-177823
Published: 2023
Journal Articles

Low Socioeconomic Status Confers Poorer Real-World Overall Survival for Patients with Acute Myeloid Leukemia Treated in the Modern Era

Mark A Guinter, Brendan T Kerr, Gregory S Calip, Anita J Kumar, Ahmed Sawas
Journal: Blood
Blood (2023) 142 (Supplement 1): 2437.
https://doi.org/10.1182/blood-2023-186137
Published: 2023
Journal Articles

Treatment Modalities Effect on Outcome in Post-Transplant Lymphoproliferative Disorder

Maegan Ford, Evelyn Orlando, Zhezhen Jin, Andrew H. Lipsky, Ahmed Sawas, Barbara Pro, Jennifer E. Amengual
Journal: Blood
Blood (2022) 140 (Supplement 1): 3794–3795.
https://doi.org/10.1182/blood-2022-163813
Published: 2022
Journal Articles

Prevalence and Characterization of EBV-Negative Post-Transplant Lymphoproliferative Disorder

Maegan Ford, Evelyn Orlando, Zhezhen Jin, Andrew H. Lipsky, Ahmed Sawas, Barbara Pro, Jennifer E. Amengual
Journal: Blood
Blood (2022) 140 (Supplement 1): 3777–3778.
https://doi.org/10.1182/blood-2022-160147
Published: 2022
Journal Articles

Impacts of the COVID-19 Pandemic on Assessment of M-Protein and Free Light Chain Levels in Patients with Multiple Myeloma

James Roose, Yichen Lu, Amy E Pierre, Ahmed Sawas, Gregory S Calip
Journal: Blood
Blood (2022) 140 (Supplement 1): 13191–13193.
https://doi.org/10.1182/blood-2022-159044
Published: 2022
Journal Articles

The Effect of Rituximab Treatment and Reducing Immunosuppression on the Development of Post-Transplant Lymphoproliferative Disorder in EBV-Positive Patients after Solid Organ Transplantation

Evelyn Orlando, Maegan Ford, Zhezhen Jin, Andrew H. Lipsky, Ahmed Sawas, Barbara Pro, Jennifer E. Amengual
Journal: Blood
Blood (2022) 140 (Supplement 1): 12085–12086.
https://doi.org/10.1182/blood-2022-158050
Published: 2022
Journal Articles

Clinical Outcomes of Solid Organ Transplant Patients with Epstein-Barr Virus-Driven (EBV + ) Post-Transplant Lymphoproliferative Disorder (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study

Vikas Dharnidharka, Dhanalakshmi Thirumalai, Ulrich Jaeger, Weizhi Zhao, Daan Dierickx, Pengcheng Xun, Periana Minga, Ahmed Sawas, Natalia Sadetsky, Paul Chauvet, Erin Sundaram, Arie Barlev, Heiner Zimmermann, Ralf Ulrich Trappe
Journal: Blood
Blood (2021) 138 (Supplement 1): 2528.
https://doi.org/10.1182/blood-2021-147307
Published: 2021
Journal Articles

Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies

Steven M. Horwitz, James M. Foran, Michael Maris, Jennifer Kimberly Lue, Ahmed Sawas, Craig Okada, Tatyana A. Feldman, Lubomir Sokol, Matthew Mei, Ian W. Flinn, Diego Villa, Mary-Elizabeth M. Percival, Deepa Jagadeesh, Kerry J. Savage, Oleg Akilov, Catherine S. Diefenbach, Youn H. Kim, Gloria H. Y. Lin, Tina Catalano, Penka S. Petrova, Bob Uger, Naomi Molloy, Kathleen Large, Ingmar Bruns, Stephen M. Ansell
Journal: Blood
Blood (2021) 138 (Supplement 1): 2448.
https://doi.org/10.1182/blood-2021-154490
Published: 2021
Journal Articles

Feasibility of Capturing AML Morphologic Response Assessments Using Real-World Data

Mark Guinter, Hankyul Kim, Alexandra Jacob, Hannah Wise, Kyusun Cha, Ahmed Sawas
Journal: Blood
Blood (2021) 138 (Supplement 1): 4377.
https://doi.org/10.1182/blood-2021-147291
Published: 2021
Journal Articles

Lab-Based Response Assessment Algorithm Recapitulates Investigator's Response Assessment in the Phase 3 Bellini Trial

Stefka Tyanova, Tao Xu, Mellissa Williamson, Alberto Rocci, Wan-Jen Hong, Huan Jin, Sudeep Karve, James Roose, Ahmed Sawas, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 4758.
https://doi.org/10.1182/blood-2021-147713
Published: 2021
Journal Articles

Title: Clinical and Biological Evaluation of the Novel CD30/CD16A Tetravalent Bispecific Antibody (AFM13) in Relapsed or Refractory CD30-Positive Lymphoma with Cutaneous Presentation: A Biomarker Phase Ib/IIa Study (NCT03192202)

Ahmed Sawas, MD, Pei-Hsuan Chen, Mikel Lipschitz, M.S., Scott Rodig, MD PhD, George Vlad
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-140096
Published: 2020
Journal Articles

Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies

Steven M. Horwitz, MD, James M. Foran, MD, Michael Maris, MD, Ahmed Sawas, MD, Craig Okada, MD PhD, Tatyana A. Feldman, MD, Mark D. Minden, Lubomir Sokol, MD PhD, Matthew Mei, MD, Ian W. Flinn, MD PhD, Diego Villa, MDMPH, Mary-Elizabeth M. Percival, MD, Deepa Jagadeesh, MDMPH, Kerry J. Savage, MDMSc, Oleg E. Akilov, MD PhD, Catherine Diefenbach, MD, Youn H. Kim, MD, Gloria H. Y. Lin, PhD, Tina Catalano, MSc, Penka S. Petrova, PhD, Bob Uger, PhD, Naomi Molloy, BSc, Kathleen Large, RN, MSN, Yaping Shou, MDPhD, Stephen M. Ansell, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–43.
https://doi.org/10.1182/blood-2020-136198
Published: 2020
Journal Articles

Real-World Outcomes of Patients with Diffuse Large B-Cell Lymphoma Receiving Second Line Therapy in the United States

Ahmed Sawas, MD, Constance Lau, MPH, Michael Thomson, MS, Kathleen Maignan, NP, MSN
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-141274
Published: 2020
Journal Articles

Cell of Origin and Treatment Impact on the Outcome of Monomorphic Post-Transplant Lymphoproliferative Disorder-Diffuse Large B-Cell Lymphoma Subtype

Francesca Montanari, MD, Changchun Deng, MD PhD, Ahmed Sawas, MD, Jennifer Kimberly Lue, MD, Enrica Marchi, MD, PhD, Dejan Radeski, MBBS, FRACP, FRCPA, Bin Cheng, PhD, Govind Bhagat, MD, Owen A. O'Connor, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2909.
https://doi.org/10.1182/blood-2019-131841
Published: 2019
Journal Articles

Belinostat Induces High Overall Response Rate (ORR) in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)

Ahmed Sawas, MD, Helen Ma, MD, Andrei Shustov, MD, Pamela Hsu, MS, Gajanan Bhat, Mark Acosta, PharmD, Steven M. Horwitz, MD, Owen A. O'Connor, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4050.
https://doi.org/10.1182/blood-2019-127155
Published: 2019
Journal Articles

Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

Clinical Trials & Observations
Owen A. O’Connor, Lorenzo Falchi, Jennifer K. Lue, Enrica Marchi, Cristina Kinahan, Ahmed Sawas, Changchun Deng, Francesca Montanari, Jennifer E. Amengual, Hye A. Kim, Aishling M. Rada, Karen Khan, Alice T. Jacob, Michelle Malanga, Mark M. Francescone, Renu Nandakumar, Craig R. Soderquist, David C. Park, Govind Bhagat, Bin Cheng, Alberto Risueño, Daniel Menezes, Andrei R. Shustov, Lubomir Sokol, Luigi Scotto
Journal: Blood
Blood (2019) 134 (17): 1395–1405.
https://doi.org/10.1182/blood.2019001285
Published: 2019
Includes: Supplemental data
Journal Articles

Atypical Immunophenotype Predicts Worse Prognosis in Adult T-Cell Lymphoma/Leukemia: A Retrospective Study of 63 Caribbean Patients at a New York City Tertiary Center

Bachar Samra, MD, Edwin Chiu, MD, Bo Lin, MD PhD, Eric Tam, MD BS, Babak Baseri, MD MS, Iuliana Shapira, MD, Jason Gonsky, MD PhD, Robert David Lewis, MD, Gurinder Sidhu, MD, Ahmed Sawas, MD, Evelyn O. Taiwo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2906.
https://doi.org/10.1182/blood-2018-99-111208
Published: 2018
Journal Articles

Prolonged Overall Survival (OS) in a Subset of Responders to the Combination of Brentuximab Vedotin (Bv) and Bendamustine (B) in Heavily Treated Patients with Relapsed or Refractory Hodgkin Lymphoma (HL): Results of an International Multi- Center Phase I/II Experience

Ahmed Sawas, MD, John Kuruvilla, MD, Jennifer Kimberly Lue, MD, Changchun Deng, MD PhD, Jennifer E Amengual, MD, Francesca Montanari, MD, Kerry J Savage, BSc, MD MSc, Hager Elgedawe, Diego Villa, MD, Michael Crump, MD, Joseph M Connors, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2907.
https://doi.org/10.1182/blood-2018-99-117251
Published: 2018
Journal Articles

Clinical and Biological Evaluation of the Novel CD30/CD16A Tetravalent Bispecific Antibody (AFM13) in Relapsed or Refractory CD30-Positive Lymphoma with Cutaneous Presentation: A Biomarker Phase Ib/IIa Study (NCT03192202)

Ahmed Sawas, MD, Hager Elgedawe, George Vlad, PhD, Mikel Lipschitz, M.S., Pei-Hsuan Chen, PhD, Scott J Rodig, MD, Jennifer Kimberly Lue, MD, Changchun Deng, MD PhD, Jennifer E Amengual, MD, Maher Abdul Hay, MD, Karen Khan, BSN, Laine E. Atkins, RN, Aishling M. Rada, RN, Larisa Geskin, MD, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2908.
https://doi.org/10.1182/blood-2018-99-115269
Published: 2018